Novo Nordisk Net Worth 2006-2019 | NVO

Interactive chart of historical net worth (market cap) for Novo Nordisk (NVO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novo Nordisk net worth as of June 14, 2019 is $124.52B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $124.522B $17.724B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.947B 17.04
Pfizer (PFE) United States $237.743B 13.88
Merck (MRK) United States $213.129B 18.35
Novartis AG (NVS) Switzerland $206.791B 17.87
AbbVie (ABBV) United States $116.330B 9.62
Eli Lilly (LLY) United States $108.481B 20.13
Sanofi (SNY) France $106.019B 13.07
AstraZeneca (AZN) United Kingdom $100.480B 11.57
GlaxoSmithKline (GSK) United Kingdom $99.522B 12.62
Bristol-Myers Squibb (BMY) United States $77.794B 11.49